The body is amazing and can recover very quickly once it learns how to fight the infection on its own.

It's interesting that his body learned how to fight it right after taking medication specifically designed to fight the flu. I'm not saying you're wrong...just that I trust my doctor over a guy on the Internet who does whatever it is you do for a living.

It's interesting that his body learned how to fight it right after taking medication specifically designed to fight the flu. I'm not saying you're wrong...just that I trust my doctor over a guy on the Internet who does whatever it is you do for a living.

Have you read up anything on this drug?. What it does, how it works, and when it has to be taken to do its job?

Governments have spent billions of dollars stockpiling the antiviral medication Tamiflu. Earlier reviews of the drug called into question just how effective it was, and the latest analysis, published today (April 10) in the British Medical Journal (BMJ), concludes that the money has been going “down the drain.”

An international team found that while Tamiflu might reduce the duration of flu symptoms by half a day, there’s no evidence that it reduces hospital admissions or complications of an infection. On top of that, the antiviral’s side effects include nausea and vomiting. “There is no credible way these drugs could prevent a pandemic,” Carl Heneghan, one of authors of the review and a professor at Oxford University, told reporters.

The data for this most recent review came from full study reports—data generated by clinical trials that are usually not open for scrutiny by independent researchers. Efforts by the BMJ and the research team convinced drugmaker Roche, which markets Tamiflu, to release the reports.

Fiona Godlee, an editor at BMJ, said that the picture of Tamiflu was previously much more positive than after the full study reports were disclosed. “Why did no one else demand this level of scrutiny before spending such huge sums on one drug?” she said at a press briefing. “The whole story gives an extraordinary picture of the entrenched flaws in the current system of drug regulation and drug evaluation.”